117 related articles for article (PubMed ID: 9145595)
1. Resistance of Vibrio cholerae 01 to nalidixic acid.
Jesudason MV; Saaya R
Indian J Med Res; 1997 Apr; 105():153-4. PubMed ID: 9145595
[TBL] [Abstract][Full Text] [Related]
2. [Experimental resistance of Vibrio cholerae el tor to nalidixic acid and fluoroquinolones].
Ryzhko IV; Tsuraeva RI; Lomov IuM; Shut'ko AG; Mishan'kin BN; Koroleva NS; Samokhodkina ED; Shcherbaniuk AI
Antibiot Khimioter; 2000; 45(9):7-12. PubMed ID: 11057367
[TBL] [Abstract][Full Text] [Related]
3. Fluoroquinolone-resistant Vibrio cholerae isolated during a cholera outbreak in India.
Krishna BV; Patil AB; Chandrasekhar MR
Trans R Soc Trop Med Hyg; 2006 Mar; 100(3):224-6. PubMed ID: 16246383
[TBL] [Abstract][Full Text] [Related]
4. Minimum inhibitory concentration (MIC) of some antibiotics against Vibrio cholerae O139 isolates from Pondicherry.
Vijayalakshmi N; Rao RS; Badrinath S
Epidemiol Infect; 1997 Aug; 119(1):25-8. PubMed ID: 9287939
[TBL] [Abstract][Full Text] [Related]
5. Quinolone susceptibility of Vibrio cholerae O1 & O139 isolates from Vellore.
Jesudason MV; Balaji V; Thomson CJ
Indian J Med Res; 2002 Sep; 116():96-8. PubMed ID: 12619447
[TBL] [Abstract][Full Text] [Related]
6. Diversity of Vibrio cholerae strains isolated in Delhi, India, during 1992-2000.
Das S; Gupta S
J Health Popul Nutr; 2005 Mar; 23(1):44-51. PubMed ID: 15884751
[TBL] [Abstract][Full Text] [Related]
7. Emergence of nalidixic acid resistant Vibrio cholerae O-1 in Karachi.
Mahmood A
J Pak Med Assoc; 1999 Nov; 49(11):286. PubMed ID: 10647244
[No Abstract] [Full Text] [Related]
8. [Quinolone resistance in Salmonella enterica].
Seral C; López L; Castillo FJ; Clavel A; Rubio MC
Rev Esp Quimioter; 1998 Mar; 11(1):43-6. PubMed ID: 9795288
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of multidrug-resistant strains of Vibrio cholerae, in a cholera outbreak in Tehran-Iran, during June-September 2008.
Ranjbar M; Rahmani E; Nooriamiri A; Gholami H; Golmohamadi A; Barati H; Rajabifar D; Barati S; Sabet MS; Zamiri A; Haghighi S; Taifehashemi P; Nojomi M
Trop Doct; 2010 Oct; 40(4):214-6. PubMed ID: 20709810
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Ciprofloxacin for Treatment of Cholera Associated with Diminished Susceptibility to Ciprofloxacin to Vibrio cholerae O1.
Khan WA; Saha D; Ahmed S; Salam MA; Bennish ML
PLoS One; 2015; 10(8):e0134921. PubMed ID: 26271050
[TBL] [Abstract][Full Text] [Related]
11. Emergence of nalidixic acid resistance in Shigella sonnei isolated from patients having acute diarrheal disease: report from eastern province of Saudi Arabia.
Panhotra BR; Saxena AK; Al-Mulhim K
Jpn J Infect Dis; 2004 Jun; 57(3):116-8. PubMed ID: 15218222
[TBL] [Abstract][Full Text] [Related]
12. Validity of nalidixic acid screening in fluoroquinolone-resistant typhoid salmonellae.
Butt T; Khan MY; Ahmad RN; Salman M; Afzal RK
J Coll Physicians Surg Pak; 2006 Jan; 16(1):31-4. PubMed ID: 16441985
[TBL] [Abstract][Full Text] [Related]
13. A study of V. cholerae strains isolated in Bombay.
Saraswathi K; Deodhar LP
J Postgrad Med; 1990 Jul; 36(3):128-30. PubMed ID: 2102910
[TBL] [Abstract][Full Text] [Related]
14. Trend of antibiotic resistance of Vibrio cholerae strains from East Delhi.
Das S; Saha R; Kaur IR
Indian J Med Res; 2008 May; 127(5):478-82. PubMed ID: 18653912
[TBL] [Abstract][Full Text] [Related]
15. Resistance of shigella to nalidixic acid & fluorinated quinolones.
Thirunarayanan MA; Jesudason MV; John TJ
Indian J Med Res; 1993 Nov; 97():239-41. PubMed ID: 8144205
[TBL] [Abstract][Full Text] [Related]
16. Serovar, biotype, phage type, toxigenicity & antibiotic susceptibility patterns of Vibrio cholerae isolated during two consecutive cholera seasons (1989-90) in Calcutta.
Ramamurthy T; Pal A; Bhattacharya MK; Bhattacharya SK; Chowdhury AS; Takeda Y; Takeda T; Pal SC; Nair GB
Indian J Med Res; 1992 May; 95():125-9. PubMed ID: 1506061
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
[TBL] [Abstract][Full Text] [Related]
18. Outbreak of cholera caused by Vibrio cholerae 01 intermediately resistant to norfloxacin at Malda, West Bengal.
Bhattacharya MK; Ghosh S; Mukhopadhyay AK; Deb A; Bhattacharya SK
J Indian Med Assoc; 2000 Jul; 98(7):389-90. PubMed ID: 11143861
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with virulence and survival in environmental and clinical isolates of Vibrio cholerae O1 and non O1 in Romania.
Israil A; Balotescu C; Bucurenci N; Năcescu N; Cedru C; Popa C; Ciufecu C
Roum Arch Microbiol Immunol; 2003; 62(3-4):155-77. PubMed ID: 16008141
[TBL] [Abstract][Full Text] [Related]
20. [Growing incidence of nalidixic acid resistance and sensitivity to quinolones in Salmonella typhimurium strains isolated from man or animal].
Heurtin-Le Corre C; Donnio PY; Bonnier M; Travert MF; Lacourt A; Avril JL
Pathol Biol (Paris); 1998 Oct; 46(8):587-90. PubMed ID: 9871929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
